Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucoadhesive polydopamine-coated nanoparticle-mediated inner ear drug delivery for hearing loss treatment.

Journal of translational medicine·2025
Same author

A sensorineural hearing loss harboring novel compound heterozygous variant in the <i>TRIOBP</i> gene: A case report.

Heliyon·2024
Same author

Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection.

Carbohydrate polymers·2024
Same author

Effect of Aging on Speech Discrimination.

Journal of audiology & otology·2022
Same author

Factors Affecting the Extrusion Rate and Complications After Ventilation Tube Insertion: A Multicenter Registry Study on the Effectiveness of Ventilation Tube Insertion in Pediatric Patients With Chronic Otitis Media With Effusion-Part II.

Clinical and experimental otorhinolaryngology·2022
Same author

Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss.

Drug delivery·2021

Related Experiment Video

Updated: May 12, 2026

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
09:18

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection

Published on: March 8, 2017

13.4K

Recent Advances in Functionalized Nanoparticles for Targeted and Controlled Inner Ear Therapy via Localized Cochlear

Dong-Kee Kim1

  • 1Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Journal of Audiology & Otology
|July 31, 2025
PubMed
Summary
This summary is machine-generated.

Functionalized nanoparticles offer targeted delivery for sensorineural hearing loss (SNHL) treatment. These advanced systems improve drug penetration and cellular uptake, showing promise for inner ear therapies.

Keywords:
Inner ear drug deliveryNanoparticlesSensorineural hearing lossSurface functionalization

More Related Videos

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

10.1K
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
09:34

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

11.0K

Related Experiment Videos

Last Updated: May 12, 2026

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
09:18

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection

Published on: March 8, 2017

13.4K
Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

10.1K
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
09:34

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

11.0K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Otolaryngology

Background:

  • Sensorineural hearing loss (SNHL) presents treatment challenges due to inner ear complexity and barriers like the blood-labyrinth barrier.
  • Nanoparticle-based drug delivery systems are emerging as a viable strategy for targeted and sustained inner ear therapeutics.

Purpose of the Study:

  • To review recent advancements in nanoparticle functionalization for enhanced inner ear drug delivery.
  • To highlight strategies for improving cochlear targeting and therapeutic efficacy in SNHL treatment.

Main Methods:

  • Discussion of active targeting strategies using prestin-specific peptides for outer hair cell delivery.
  • Exploration of stimuli-responsive systems (thermosensitive hydrogels, light-activated nanoparticles) for controlled drug release.
  • Analysis of surface modifications (PEGylation, cell-penetrating peptides, cationic charges) to enhance round window membrane permeability and cellular uptake.

Main Results:

  • Functionalized nanoparticles demonstrate improved cochlear targeting in preclinical SNHL models.
  • Surface modifications enhance drug delivery across the round window membrane and increase cellular uptake.
  • Stimuli-responsive systems enable controlled drug release, optimizing therapeutic potential.

Conclusions:

  • Advanced nanoparticle functionalization strategies show significant promise for treating SNHL.
  • Multifunctional, biocompatible nanoparticle systems are crucial for successful clinical translation.
  • Targeted and stimuli-responsive drug delivery via nanoparticles offers a promising therapeutic avenue for sensorineural hearing loss.